Koyo Fujii

Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study

E. Okajima, M. Miyake, N. Tanaka, 2022, Cancers.